Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
3 of 6 columns
Comparison
| Attribute | Enumera Molecular, Inc.7.1remove | Dozee Inc.7.0remove | Samothrace Medical Innovations Inc.6.9remove |
|---|---|---|---|
| Signal scores | |||
| Radar composite | 7.1 | 7.0 | 6.9 |
| IPO signal score | 14.2 | 13.9 | 13.8 |
| Tokenization signal score | 0.0 | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 | 0.0 |
| Momentum | STABLE0.0 | STABLE+3.9 | STABLE+3.3 |
| Company | |||
| Stage | private | private | private |
| Sector | Health Care | Health Care | Health Care |
| Headquarters | ANN ARBOR, United States | HOUSTON, United States | DANIEL ISLAND, United States |
| Founded | 2022 | 2023 | 2022 |
| Employees | not on record | not on record | not on record |
| Capital | |||
| Latest valuation | not on record | not on record | not on record |
| Total funding | $12M | $10M | $5M |
| Latest round | Private Placement $12M | Private Placement $10M | Private Placement $5M |
| Investors on record | 0 | 0 | 0 |
| Evidence | |||
| Institutional relationships | 0 | 0 | 0 |
| Active signals | 1 | 2 | 1 |
| Confidence | 53% | 56% | 53% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.